Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2‐positive recurrent serous carcinoma of the uterine cervix: A case report

Documenti analoghi

• A case of BRAF mutation‐positive recurrent ovarian high‐grade serous carcinoma with remarkable response to combined dabrafenib and trametinib therapy
  di: Tatsuhito Furui, et al.
  Pubblicazione: (2025)
• Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern
  di: Azusa Sakurai, et al.
  Pubblicazione: (2024)
• Retrospective analysis of treatment and prognosis for clear cell carcinoma of the uterine cervix: 15‐year experience at a single institution
  di: Yusuke Inomata, et al.
  Pubblicazione: (2025)
• Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study
  di: Serena Negri, et al.
  Pubblicazione: (2024)
• A case of uterine liposarcoma with PLAG1 rearrangement that was difficult to classify into established subtypes
  di: Junka Koyama, et al.
  Pubblicazione: (2025)